Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDIC COSMETIC LASER CLINIC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   1.1% 2.5% 1.5% 2.9% 5.6% 4.4% 11.3% 11.3%   Credit score (0-100)   87 63 77 57 40 46 22 22   Credit rating   A BBB A BBB BBB BBB BB BB   Credit limit (kDKK)   224.3 0.0 23.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   196 21.1 155 142 -117 25.8 0.0 0.0   EBITDA   150 -17.8 83.0 83.9 -188 -64.1 0.0 0.0   EBIT   150 -17.8 83.0 83.9 -188 -64.1 0.0 0.0   Pre-tax profit (PTP)   867.0 -600.5 394.6 -968.9 -178.0 -422.8 0.0 0.0   Net earnings   833.6 -603.2 275.2 -994.0 -189.5 -435.5 0.0 0.0   Pre-tax profit without non-rec. items   867 -600 395 -969 -178 -423 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   4,784 4,181 4,456 3,462 1,367 932 807 807   Interest-bearing liabilities   130 287 293 1,290 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,159 4,707 5,131 4,755 1,452 1,188 807 807   Net Debt   128 270 138 1,271 -20.4 -7.4 -807 -807     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   196 21.1 155 142 -117 25.8 0.0 0.0   Gross profit growth   -44.0% -89.2% 632.2% -8.2% 0.0% 0.0% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,159 4,707 5,131 4,755 1,452 1,188 807 807   Balance sheet change%   15.9% -8.8% 9.0% -7.3% -69.5% -18.2% -32.1% 0.0%   Added value   149.8 -17.8 83.0 83.9 -187.9 -64.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -4 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 2.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   76.6% -84.4% 53.7% 59.1% 160.7% -248.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   23.6% -1.0% 8.9% 15.5% 30.2% 0.4% 0.0% 0.0%   ROI %   19.3% -12.6% 8.7% -20.0% -5.5% -36.0% 0.0% 0.0%   ROE %   19.1% -13.5% 6.4% -25.1% -7.9% -37.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   92.7% 88.8% 86.8% 72.8% 94.2% 78.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   85.7% -1,512.8% 165.6% 1,514.1% 10.9% 11.5% 0.0% 0.0%   Gearing %   2.7% 6.9% 6.6% 37.3% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.5% 3.7% 2.5% 2.1% 1.6% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   0.0 0.1 0.2 0.0 2.7 0.9 0.0 0.0   Current Ratio   0.0 0.1 0.2 0.0 2.7 0.9 0.0 0.0   Cash and cash equivalent   1.8 17.7 155.7 19.1 20.4 7.4 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -370.5 -479.3 -510.9 -1,254.7 147.7 -21.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0